Biogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biogen and other ETFs, options, and stocks.

About BIIB

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. 

CEO
Christopher A. Viehbacher
CEOChristopher A. Viehbacher
Employees
7,570
Employees7,570
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1978
Founded1978
Employees
7,570
Employees7,570

BIIB Key Statistics

Market cap
31.89B
Market cap31.89B
Price-Earnings ratio
27.50
Price-Earnings ratio27.50
Dividend yield
Dividend yield
Average volume
1.43M
Average volume1.43M
High today
$220.56
High today$220.56
Low today
$217.64
Low today$217.64
Open price
$220.34
Open price$220.34
Volume
1.33M
Volume1.33M
52 Week high
$319.76
52 Week high$319.76
52 Week low
$215.35
52 Week low$215.35

BIIB News

Benzinga 14h
Spotlight on Biogen: Analyzing the Surge in Options Activity - Biogen - Benzinga

Loading... Loading... Investors with a lot of money to spend have taken a bullish stance on Biogen BIIB. And retail traders should know. We noticed this toda...

Spotlight on Biogen: Analyzing the Surge in Options Activity - Biogen - Benzinga
Yahoo Finance 5d
Why Is Biogen Inc. Up 2.6% Since Last Earnings Report? - Yahoo Finance

It has been about a month since the last earnings report for Biogen Inc. (BIIB). Shares have added about 2.6% in that time frame, underperforming the S&P 500....

Why Is Biogen Inc. Up 2.6% Since Last Earnings Report? - Yahoo Finance
Yahoo Finance 7d
Biogen Inc. Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

In the latest market close, Biogen Inc. (BIIB) reached $227.36, with a -1.18% movement compared to the previous day. This move lagged the S&P 500's daily gain o...

Biogen Inc. Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Analyst ratings

74%

of 35 ratings
Buy
74.3%
Hold
25.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.